Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4295-4298, August 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smidt, M.
Right arrow Articles by Ratner, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smidt, M.
Right arrow Articles by Ratner, L.

Structure and Expression of the c-sis Gene and Its Relationship to Sporadic Meningiomas1

Mary Smidt, J. P. Dumanski, V. Peter Collins and Lee Ratner2

Departments of Medicine and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110 [M. S., L. R.]; Ludwig Institute for Cancer Research, Karolinska Institute, Stockholm, Sweden [J. P. D., V. P. C.]; and Department of Clinical Genetics, Karolinska Institute, Stockholm, Sweden S-10401 [J. P. D.]

A deletion in an Alu repetitive sequence in the fifth intron of the c-sis gene of meningioma patients was previously described (M. Smidt et al., J. Clin. Invest., 86: 1151–1157, 1990). The authors analyzed the structure of this intron in DNA from peripheral blood leukocytes and tumor samples of 86 patients with sporadic meningiomas. After amplifying these DNA sequences by the polymerase chain amplification reaction, the authors failed to find any cases with deletions. They also analyzed the effects on the expression of c-sis of the fifth intron with or without the deletion. A c-sis expression clone with an SV40 promoter was modified by adding introns 4, 5, and 6, and the resulting clones were used to examine the expression of c-sis mRNA in A172, NIH3T3, and Cos-7 cells. Northern blots showed that the quantity of message was not changed when the introns were present and that the size of the message was not changed by the deletion in the fifth intron. The effect of the fifth intron Alu sequence on the c-sis promoter was also tested using clones with chloramphenicol acetyltransferase as a reporter gene in A172 and Cos-7 cells. The c-sis promoter was not affected by the fifth intron Alu sequence with or without the deletion and in either orientation. There were also no effects when cells were stimulated by phorbol 12-myristate 13-acetate or the regulatory gene Tax from human T-lymphotropic virus type 1. These data do not support a role for deletions in the fifth c-sis intron in the development of most sporadic meningiomas.

1 Supported by a collaborative Washington University-Monsanto/Searle-Research agreement and by the Swedish Cancer Society.

2 American Cancer Society Research Professor. To whom requests for reprints should be addressed.

Received 4/ 9/91. Accepted 6/ 4/91.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.